CASE REPORT
Year : 2021  |  Volume : 8  |  Issue : 6  |  Page : 168-171

Pharmacomechanical catheter-directed thrombolysis: An emerging therapy for deep vein thrombosis – A case series


Department of Cardiology, Mahatma Gandhi Medical College and Research Institute, Puducherry, India

Correspondence Address:
Srinivasan Giridharan
Department of Cardiology, Mahatma Gandhi Medical College and Research Institute, Puducherry
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijves.ijves_1_21

Rights and Permissions

Venous thromboembolism comprising pulmonary embolism and deep-vein thrombosis (DVT) is a major health problem with DVT accounting for two-third of them. Lower extremity DVTs account for 25%–50% of them and have long-term chronic venous complications which are termed as postthrombotic syndrome. The armamentarium in DVT management includes systemic anticoagulation, mechanical thrombectomy, and catheter-directed thrombolysis (CDT). Despite the benefits of therapy, CDT has its own limitations. Pharmacomechanical CDT (PMCDT) is an emerging percutaneous therapy which improves the treatment efficacy and reduces the incidence of long-term complications. Here, we present a series of three cases where PMCDT was used in acute to subacute DVT with poor response to anticoagulation therapy.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed590    
    Printed18    
    Emailed0    
    PDF Downloaded46    
    Comments [Add]    

Recommend this journal